Taurine Supplementation: A Promising Strategy for Managing Metabolic Syndrome

A recent study published in Nutrition & Diabetes conducted a meta-analysis of randomized clinical trials (RCTs) to evaluate the effects of taurine supplementation on metabolic syndrome (MetS). MetS is characterized by abdominal obesity, hypertension, hyperglycemia, hypertriglyceridemia, and low HDL cholesterol, increasing the risk of cardiovascular diseases and type 2 diabetes. Taurine has been identified as a potential treatment due to its role in mitochondrial function, osmoregulation, and antioxidant defense. The meta-analysis included 25 trials with 1,024 participants and found that taurine significantly reduced systolic blood pressure (−4 mmHg), diastolic blood pressure (−1.5 mmHg), fasting blood glucose (−5.9 mg/dL), and triglycerides (−18.3 mg/dL), though it had no significant effect on HDL levels. The findings suggest taurine may improve MetS outcomes by enhancing glycemic control and cardiovascular health, warranting further studies on optimal dosage and duration of taurine therapy for MetS management.

Source: https://www.nature.com/articles/s41387-024-00289-z